Back to news

Microbot Medical® Files 10-Q and Highlights Key Third Quarter Operating Achievements

Globe Newswire•16/11/2026•08:30 ET
0

Key Highlights

  • ➤Q3 revenue $72,000, down from $241,000 in Q2
  • ➤LIBERTY utilization rose 44% sequentially during the third quarter
  • ➤Cash, cash equivalents and marketable securities totaled approximately $62 million
  • ➤Customer accounts increased to 12 from 10 in the second quarter
  • ➤Management expects positive gross margin during 2027 if cost initiatives succeed

Expert Statements

Harel Gadot, CEO, President and Chairman of Microbot Medical

“In less than six months since the full market release of the LIBERTY System, we are encouraged by the quality of customers we have added, and we believe their repeat purchases reflect their satisfaction with LIBERTY”

Harel Gadot, CEO, President and Chairman of Microbot Medical

“While revenue this quarter in part reflected the seasonality of the third quarter and the sales cycle process associated with the VAC, we believe the progress we made this year positions us for several potential milestones over the coming months in the U.S. and the international markets in which we operate.”

Company continues to expand commercial presence in the U.S. while it progresses international market entry and opportunities

Increased the number of health systems and hospital sites using LIBERTY, while utilization of the LIBERTY System rose 44% compared to the second quarter

Get started

Create a free account to read the full story.

Sign Up

Already have an account? Log in